Daphne Koller, insitro CEO (Stefan Wermuth/Bloomberg via Getty Images)

Q&A: In­sitro CEO Daphne Koller on ‘po­ten­tial­ly de­struc­tive’ AI hype, Nvidi­a's chips, and biotech's da­ta prob­lem

SAN JOSE, CA — For all its promise, ar­ti­fi­cial in­tel­li­gence has rou­tine­ly fall­en in­to the hype trap.

Daphne Koller, a self-de­scribed “OG AI per­son,” hopes biotech can steer clear this time around, while not be­ing par­tic­u­lar­ly op­ti­mistic her­self about the chances of tamp­ing down ex­cite­ment to healthy lev­els. Koller, 55, has been work­ing in AI for about three decades, start­ing as a Stan­ford Uni­ver­si­ty pro­fes­sor in 1995 and join­ing Al­pha­bet’s biotech Cal­i­co Life Sci­ences as its chief com­put­ing of­fi­cer in 2016.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.